Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 8/20 | 0.46 |
| ▸ | F2 | P00734 | 2/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.41 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.41 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.41 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29392308 | 1.00 | ENPEP (0.46) | ENPEPF2PTPN1GRIN2DGRIN3B | |
| SCHEMBL30539294 | 0.94 | ENPEP (0.50) | ENPEPF2 | |
| SCHEMBL30781479 | 0.87 | GRIN2D (0.47) | ENPEPGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL30781484 | 0.87 | GRIN2D (0.47) | ENPEPGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL31574020 | 0.84 | ENPEP (0.53) | ENPEP | |
| SCHEMBL38663438 | 0.84 | ENPEP (0.52) | ENPEPF2 | |
| SCHEMBL29349500 | 0.83 | ENPEP (0.52) | ENPEP | |
| SCHEMBL5356649 | 0.82 | ENPEP (0.53) | ENPEP | |
| SCHEMBL5356653 | 0.82 | ENPEP (0.53) | ENPEP | |
| SCHEMBL10590691 | 0.82 | ENPEP (0.53) | ENPEPGRIN2DGRIN3BGRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216329-A1 | PUTRESCINE TOPICAL FORMULATIONS | VIVIER CANADA INC. (CA) | 2024-07-04 | — | — | US | disclosed |
| US-20240197608-A1 | ACETYL SH-HEXAPEPTIDE-5 AMIDE ACETATE FOR USE IN THE TREATMENT OF HAIR LOSS DISORDERS AND AS A HAIR CARE AGENT | LABORATORIO GENOVE, S.A. (ES) | 2024-06-20 | — | — | US | disclosed |
| EP-4326305-A1 | ACETYL SH-HEXAPEPTIDE-5 AMIDE ACETATE FOR USE IN THE TREATMENT OF HAIR LOSS DISORDERS AND AS A HAIR CARE AGENT | Laboratorio Genove, S.A. (ES) | 2024-02-28 | — | — | EP | disclosed |
| CN-110772446-B | Skin repair polypeptide composition of water-in-oil system | 深圳市维琪科技股份有限公司 | 2023-08-22 | — | — | CN | disclosed |
| US-20230117640-A1 | PUTRESCINE TOPICAL FORMULATIONS | VIVIER CANADA INC (CA) | 2023-04-20 | — | — | US | disclosed |
| WO-2022223525-A1 | ACETYL SH-HEXAPEPTIDE-5 AMIDE ACETATE FOR USE IN THE TREATMENT OF HAIR LOSS DISORDERS AND AS A HAIR CARE AGENT | LABORATORIO GENOVE, S.A. (ES) | 2022-10-27 | — | — | WO | disclosed |
| US-20210275495-A1 | PUTRESCINE TOPICAL FORMULATIONS | VIVIER CANADA INC. (CA) | 2021-09-09 | — | — | US | disclosed |
| CN-110840751-A | Water-in-oil breast augmentation polypeptide composition | 宇肽生物(东莞)有限公司 | 2020-02-28 | — | — | CN | disclosed |
| CN-110772446-A | Water-in-oil system skin repair polypeptide composition | 深圳市维琪医药研发有限公司 | 2020-02-11 | — | — | CN | disclosed |